[Epidemiology and economy of Helicobacter pylori infections].
Schröder-Bernhardi
D
D
IMS HEALTH, Frankfurt/M., Germany.
Perez
E
E
Dietlein
G
G
D003362:Cost-Benefit Analysis; D016208:Databases, Factual; D004359:Drug Therapy, Combination; D005756:Gastritis / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology*; D005858:Germany; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D010437:Peptic Ulcer / Q000191:economics / Q000453:epidemiology*